A Lewis lung carcinoma mouse model and a lung squamous cell carcinoma humanized mouse model were used to investigate the combined efficacy and safety of SMI and PD-1 inhibitor. The gene discussed is PDCD1; the disease is squamous cell lung carcinoma.